PARRY, ROMANI, DECONCINI & SYMMS for FAGRON
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 21, 2019 | $5,716 | Replaced |
| 3rd Quarter - Termination | Jan 17, 2020 | $5,716 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B) is in alignment with the statutory language. Legislation efforts include working on guidance documents issued by FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.